Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Change in Inventory (2019 - 2025)

Outset Medical (OM) has disclosed Change in Inventory for 7 consecutive years, with -$1.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Inventory rose 30.02% to -$1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$11.8 million, a 208.62% decrease, with the full-year FY2025 number at -$11.8 million, down 208.62% from a year prior.
  • Change in Inventory was -$1.5 million for Q4 2025 at Outset Medical, up from -$3.0 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $11.1 million in Q2 2022 to a low of -$3.7 million in Q1 2025.
  • A 5-year average of $1.7 million and a median of $1.7 million in 2022 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: soared 979.49% in 2021, then plummeted 1235.11% in 2025.
  • Outset Medical's Change in Inventory stood at $4.1 million in 2021, then crashed by 171.95% to -$3.0 million in 2022, then surged by 132.41% to $960000.0 in 2023, then tumbled by 322.08% to -$2.1 million in 2024, then surged by 30.02% to -$1.5 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Change in Inventory are -$1.5 million (Q4 2025), -$3.0 million (Q3 2025), and -$3.6 million (Q2 2025).